Batyrkhan is a global Market Access and HEOR leader with 14 years of experience across affiliate, regional, and global roles. His work focuses on shaping evidence, value, and access strategies for innovative therapies, with a particular focus on rare diseases. He brings experience across HEOR, RWE, HTA, pricing and reimbursement, and patient-centered evidence, translating complex evidence into better access, stronger decisions, and business value.